These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8942075)

  • 41. Distinctive KIR and HLA diversity in a panel of north Indian Hindus.
    Rajalingam R; Krausa P; Shilling HG; Stein JB; Balamurugan A; McGinnis MD; Cheng NW; Mehra NK; Parham P
    Immunogenetics; 2002 Mar; 53(12):1009-19. PubMed ID: 11904677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.
    Wagtmann N; Rajagopalan S; Winter CC; Peruzzi M; Long EO
    Immunity; 1995 Dec; 3(6):801-9. PubMed ID: 8777725
    [No Abstract]   [Full Text] [Related]  

  • 43. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis.
    Wu MY; Yang JH; Chao KH; Hwang JL; Yang YS; Ho HN
    Fertil Steril; 2000 Dec; 74(6):1187-91. PubMed ID: 11119748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Killer immunoglobulin-like receptor gene distribution in Guangdong Han population].
    Yin XL; Guo KY; Ma HJ; Shang ZC; Xiao LL; Ye X; Zhao Y
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1416-8. PubMed ID: 15604074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.
    Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF
    J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients.
    Cosentini E; Gargiulo L; Bruno P; Lastraioli S; Risitano A; Camerlingo R; Luongo V; Serra M; Sica M; Garzillo C; Giani U; Notaro R; Alfinito F; Ruggiero G; Terrazzano G
    Tissue Antigens; 2012 Oct; 80(4):322-7. PubMed ID: 22803950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
    Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
    J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
    Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
    J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.
    van der Slik AR; Koeleman BP; Verduijn W; Bruining GJ; Roep BO; Giphart MJ
    Diabetes; 2003 Oct; 52(10):2639-42. PubMed ID: 14514651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 'Unleashed' natural killers hinder HIV.
    Altfeld M; Goulder P
    Nat Genet; 2007 Jun; 39(6):708-10. PubMed ID: 17534364
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
    Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A
    Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C.
    Fry AM; Lanier LL; Weiss A
    J Exp Med; 1996 Jul; 184(1):295-300. PubMed ID: 8691146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
    Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
    Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
    Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of a human natural killer cell inhibitory receptor.
    Fan QR; Mosyak L; Garboczi DN; Winter CC; Wagtmann N; Long EO; Wiley DC
    Transplant Proc; 1999 Jun; 31(4):1871-2. PubMed ID: 10371978
    [No Abstract]   [Full Text] [Related]  

  • 57. HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells.
    Husain Z; Levitan E; Larsen CE; Mirza NM; Younes S; Yunis EJ; Alper CA; Dubey DP
    J Clin Immunol; 2002 Jan; 22(1):28-36. PubMed ID: 11958591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells.
    Chwae YJ; Chang MJ; Park SM; Yoon H; Park HJ; Kim SJ; Kim J
    J Immunol; 2002 Oct; 169(7):3726-35. PubMed ID: 12244166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of killer cell immunoglobulin-like receptors in the Greek population.
    Niokou D; Spyropoulou-Vlachou M; Darlamitsou A; Stavropoulos-Giokas C
    Hum Immunol; 2003 Dec; 64(12):1167-76. PubMed ID: 14630399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.
    Valiante NM; Uhrberg M; Shilling HG; Lienert-Weidenbach K; Arnett KL; D'Andrea A; Phillips JH; Lanier LL; Parham P
    Immunity; 1997 Dec; 7(6):739-51. PubMed ID: 9430220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.